safingol has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cox, SB; Holliday, MW; Kang, MH; Maurer, BJ | 1 |
1 other study(ies) available for safingol and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
C22:0- and C24:0-dihydroceramides confer mixed cytotoxicity in T-cell acute lymphoblastic leukemia cell lines.
Topics: Antineoplastic Agents; Autophagy; Cell Line, Tumor; Ceramides; Culture Media; DNA Fragmentation; Fatty Acids; Humans; Mitochondria; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Sphingolipids; Sphingosine | 2013 |